Pronađeno: 11-20 / 144 radova

Autori: Zaric Bojan

>> Filter: Samo Article i Review

Naslov Prevalence of respiratory symptoms and lung diseases in lung cancer screening program (Meeting Abstract)
Autori Djekic-Malbasa Jelena N  Kovacevic Tomi S  Milenkovic Ana M  Zaric Bojan  Stojanovic Goran  Bokan Darijo 
Info EUROPEAN RESPIRATORY JOURNAL, (2023), vol. 62 br. , Suppl. 67, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Results and challenges of lung cancer screening in Serbia (Meeting Abstract)
Autori Djekic-Malbasa Jelena N  Kovacevic Tomi S  Zaric Bojan  Bokan Darijo  Dragisic Dragan  Stojanovic Goran 
Info EUROPEAN RESPIRATORY JOURNAL, (2023), vol. 62 br. , Suppl. 67, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Improving the Lives of Patients Diagnosed with Lung Carcinoma: The Holistic Power of Palliative Care (Meeting Abstract)
Autori Kovacevic Tomi S  Zaric Bojan  Bursac Daliborka S  Djekic-Malbasa Jelena N  Stojanovic Goran  Bokan Darijo 
Info JOURNAL OF THORACIC ONCOLOGY, (2023), vol. 18 br. 11, Suppl. S, str. S728-S728
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Influence of psychiatric disorders on survival in patients with lung cancer: Real-world data (Meeting Abstract)
Autori Kovacevic Tomi S  Bokan Darijo  Djekic-Malbasa Jelena N  Zaric Bojan  Bursac Daliborka S  Stojanovic Goran  Simurdic Petar V  Stojsic Vladimir N 
Info ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 2, str. S1090-S1090
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Management of paresthesia in patients treated with lazertinib: Integrated analysis of LASER201 and LASER301 studies (Meeting Abstract)
Autori Lee Y-G  ...  Zaric Bojan  ...  (broj koautora 16) 
Info ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 2, str. -
Projekat Yuhan
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301 (Article)
Autori Cho Byoung Chul  ...  Zaric Bojan 
Info JOURNAL OF CLINICAL ONCOLOGY, (2023), vol. 41 br. 26, str. 4208-+
Projekat The authors would like to thank all the patients who participated in this study and their families and caregivers. The authors would also like to thank the physicians and nurses who cared for the patients and the staff at the clinical sites.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Real-world data on survival outcomes and characteristics of lung cancer patients in northern serbia. (Meeting Abstract)
Autori Bokan Darijo  Zaric Bojan  Kovacevic Tomi S  Stojanovic Goran  Djekic-Malbasa Jelena N 
Info JOURNAL OF CLINICAL ONCOLOGY, (2023), vol. 41 br. 16, Suppl. S, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Decade of lung cancer in Serbia: tobacco abuse and gender differences (Article)
Autori Djekic-Malbasa Jelena N  Kovacevic Tomi S  Zaric Bojan  Dugandzija Tihomir  Nikolin Borislava  Radovanovic Dragana R  Paut-Kusturica Milica M 
Info EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, (2023), vol. 27 br. 7, str. 3105-3116
Projekat Provincial Secretariat for Higher Education and Scientific Research project [142- 451-2621/2021-01]
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Prognostic Role of Monocyte Distribution Width, CRP, Procalcitonin and Lactate as Sepsis Biomarkers in Critically Ill COVID-19 Patients (Article)
Autori Bajic Dejana D  Matijasevic Jovan A  Andrijevic Ljiljana N  Zaric Bojan  Lalic-Popovic Mladena N  Andrijevic Ilija  Todorovic Nemanja B  Mihajlovic Andrea N  Tapavicki Borislav  Ostojic Jelena V 
Info JOURNAL OF CLINICAL MEDICINE, (2023), vol. 12 br. 3, str. -
Projekat Project of the Ministry of Education, Science and Technological Development, Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina, Republic of Serbia [142-451-3176/2022-01]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829) (Meeting Abstract)
Autori Cho Byoung Chul  ...  Zaric Bojan 
Info ANNALS OF ONCOLOGY, (2022), vol. 38 br. 9, Suppl. 9, str. S1560-S1560
Projekat Yuhan Corporation
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Ispis zapisa u formatu:TXT | BibTeX